Alzheimers-Disease-Information-Page

Alzheimer's Disease Information Page


What research is being done?

The National Institute of Neurological Disorders and Stroke (NINDS) supports basic and translational research related to AD through grants to major medical institutions across the country. Current studies are investigating how the development of beta amyloid plaques damages neurons, and how abnormalities in tau proteins create the characteristic neurofibrillary tangles of AD. Other research is exploring the impact of risk factors associated with the development of AD, such as pre-existing problems with blood flow in the blood vessels of the brain. Most importantly, the NINDS supports a number of studies that are developing and testing new and novel therapies that can relieve the symptoms of AD and potentially lead to a cure.

On May 15, 2012 the Obama Administration announced the release of the National Alzheimer’s Plan. U.S. Secretary of Health and Human Services Kathleen Sebelius reaffirmed our nation’s commitment to conquering Alzheimer’s disease and related dementias, with a specific goal of finding effective ways to prevent and treat the disease by 2025.

Information from the National Library of Medicine’s MedlinePlus
Alzheimer's Disease
Alzheimer's Caregivers

×
What research is being done?

The National Institute of Neurological Disorders and Stroke (NINDS) supports basic and translational research related to AD through grants to major medical institutions across the country. Current studies are investigating how the development of beta amyloid plaques damages neurons, and how abnormalities in tau proteins create the characteristic neurofibrillary tangles of AD. Other research is exploring the impact of risk factors associated with the development of AD, such as pre-existing problems with blood flow in the blood vessels of the brain. Most importantly, the NINDS supports a number of studies that are developing and testing new and novel therapies that can relieve the symptoms of AD and potentially lead to a cure.

On May 15, 2012 the Obama Administration announced the release of the National Alzheimer’s Plan. U.S. Secretary of Health and Human Services Kathleen Sebelius reaffirmed our nation’s commitment to conquering Alzheimer’s disease and related dementias, with a specific goal of finding effective ways to prevent and treat the disease by 2025.

Information from the National Library of Medicine’s MedlinePlus
Alzheimer's Disease
Alzheimer's Caregivers

The National Institute of Neurological Disorders and Stroke (NINDS) supports basic and translational research related to AD through grants to major medical institutions across the country. Current studies are investigating how the development of beta amyloid plaques damages neurons, and how abnormalities in tau proteins create the characteristic neurofibrillary tangles of AD. Other research is exploring the impact of risk factors associated with the development of AD, such as pre-existing problems with blood flow in the blood vessels of the brain. Most importantly, the NINDS supports a number of studies that are developing and testing new and novel therapies that can relieve the symptoms of AD and potentially lead to a cure.

On May 15, 2012 the Obama Administration announced the release of the National Alzheimer’s Plan. U.S. Secretary of Health and Human Services Kathleen Sebelius reaffirmed our nation’s commitment to conquering Alzheimer’s disease and related dementias, with a specific goal of finding effective ways to prevent and treat the disease by 2025.

Information from the National Library of Medicine’s MedlinePlus
Alzheimer's Disease
Alzheimer's Caregivers


Definition
Definition
Treatment
Treatment
Prognosis
Prognosis
Clinical Trials
Clinical Trials
Organizations
Organizations
Publications
Publications
225 North Michigan Avenue.
Floor 17
Chicago, IL 60601-7633
Tel: 312-335-8700; 800-272-3900 (24-Hour Helpline); 312-335-5886 (TDD)
National Institute on Aging
P.O. Box 8250
Silver Spring, MD 20907-8250
Tel: 1-800-438-4380
322 Eighth Avenue
7th Floor
New York, NY 10001
Tel: 866-AFA-8484 (232-8484)
57 West 57th Street
Suite 904
New York, NY 10019
Tel: 212-901-8000
Radnor Station Building #2 Suite 320
290 King of Prussia Road
Radnor, PA 19087
Tel: 267-514-7221; 866-507-7222
22512 Gateway Center Drive
Clarksburg, MD 20871
Tel: 1- 800-437-2423
785 Market St.
Suite 750
San Francisco, CA 94103
Tel: 415-434-3388; 800-445-8106
11620 Wilshire Blvd.
Suite 270
Los Angeles, CA 90025
Tel: 310-445-4650
912 Killian Hill Road, S.W.
Lilburn, GA 30047
Tel: 404-935-6444; 800-539-9767
1731 King Street
Alexandria, VA 22314
Tel: 703-837-1500; Helpline: 800-658-8898
National Institutes of Health, DHHS
6001 Executive Blvd. Rm. 8184, MSC 9663
Bethesda, MD 20892-9663
Tel: 301-443-4513; 866-615-6464; 866-415-8051 (TTY)
55 Kenosia Avenue
Danbury, CT 06810
Tel: 203-744-0100; Voice Mail: 800-999-NORD (6673)
800 Eastowne Drive
Suite 105
Chapel Hill, NC 27514
Tel: 919-490-5577 (x222)
P.O. Box 5755
Berkeley, CA 94705
Tel: 617-545-4882
63 West Main Street
Suite H
Freehold, NJ 07728
Tel: 800-838-0879; 732-577-8899